Online Live Broadcast

9th Annual Spring to Life

Conference on Gastrointestinal Cancers 2022

April 29-30, 2022

Proudly Hosted by New York Oncology Hematology, PC

PROUDLY HOSTED BY:

EVENT INFORMATION

This is a Online Live Broadcast
Upon registration, a confirmation will be provided via email
Within 3 days of the conference, login instructions will be provided via email
PALLIATIVE CARE PROGRAM: Following the conclusion of the Healthcare Professional program, a Patient-Centered non-CME forum is being held on April 30, 2022 from 3:30-5:00pm. CLICK HERE: To attend and share this opportunity with the patients, spouses, caregivers and survivors you know and have treated.

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology

Registration

Please click here if you would like to be notified when registration is open. We hope to see you in 2020!

S2L | Registration HCP

First Name *

Last Name

Title Title

Specialty

Institution *

Street Address *

Additional Address

City *

State/Province *

ZIP/Postal *

Country *

Confirm Email

Phone

How did you hear about the conference? * How did you hear about the conference?

reCAPTCHA

Conference Platform

The 2022 Spring to Life conference will be held April 29-30, 2022 and will be an online live broadcast utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The conference will be recorded and will be offered on-demand for 30 days following the live conference.

PROGRAM OVERVIEW

The focus of the 2022 Spring to Life Conference is Gastrointestinal Cancers. New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference being held April 29-30, 2022 at spring2liferegistration.org. With an expanded agenda the conference is offering 8.0-hrs of continuing medical education. This is the ninth of these annual conferences that include programming for cancer clinicians.

EDUCATIONAL GOAL

The purpose of this conference is to educate practitioners and update their knowledge of the biological pathways, diagnosis, current guidelines, and the existing and emerging therapies for the management of patients with gastrointestinal cancers.

TARGET AUDIENCE

The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers with an interest in the care of patients with gastrointestinal cancers.

LEARNING OBJECTIVES

After completing this activity, participants will be able to:

Evaluate the optimal perioperative treatment approaches in the management of gastrointestinal cancers.
Discuss updated data on novel agents and therapeutic approaches for patients with metastatic gastrointestinal cancers.
Analyze the role of molecular biomarkers and indicated testing strategies in the care of patients with gastrointestinal malignancies.
Discuss surgical management options of liver metastases in colorectal cancers and locoregionally advanced appendix cancer.
Understand the role and indications of Interventional Radiologic treatment modalities in gastrointestinal malignancies.

DOWNLOAD AGENDA

PLANNING COMMITTEE

Ira Zackon, MD (Conference Chair)
New York Oncology Hematology, Immediate Past President
Hematologist/Medical Oncologist
NYOH Albany Medical Center
Clinical Assistant Professor
Albany Medical College
Albany, NY

Mohamad Younes, MD
Medical Oncology - Hematology
New York Oncology Hematology
Albany, NY

Madhavi Kambam, MD
Medical Oncology - Hematology
New York Oncology Hematology
Clinical Assistant Professor
Albany Medical College
Albany, NY

Faculty

Ghassan Abou-Alfa, MD, MBA
Professor
Memorial Sloan Kettering Cancer Center
New York, NY

Lindy Davis, MD, FACS
Assistant Professor of Surgery
Albany Medical Center
Albany, NY

David H. Ilson, MD PhD
Attending Physician
Gastrointestinal Oncology Service
Division of Solid Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, NY

Rebecca Keim, MD, FACS
Hepato-Pancreatic-Biliary Surgeon
St. Peter's Health Partners Medical Associates
Albany, NY

Jeffrey Meyerhardt, MD, MPH, FASCO
Chief Clinical Research Officer
Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology
Section Head, Hepatopancreaticobiliary & Neuroendocrine Cancers
Co-Director Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer
Chair, Institutional Review Board
Attending Physician, Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
New York, NY

Mitchell C. Posner M.D., FACS
Thomas D. Jones Professor of Surgery and Vice-Chairman
Chief, Section of General Surgery
and Surgical Oncology
Physician-in-Chief, UCM Comprehensive Cancer Center
Professor, Radiation and Cellular Oncology
University of Chicago Medicine
Chicago, IL

Benjamin L. Schlechter, MD
Instructor
Harvard Medical School
Attending Physician
Gastrointestinal Cancer Center
Dana Farber Cancer Institute
Boston, MA

Christopher Stark, MD
Assistant Professor of Radiology
Vascular and Interventional Radiology
Albany Medical College

Jonathan Strosberg, MD
Professor
Moffitt Cancer Center
Tampa, FL

Host

The 9th Annual Spring to Life: Conference on Gastrointestinal Cancers 2022 is proudly hosted by:

ACCREDITATION

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.

Assurance of Balanced, Unbiased, and Fair Content:

It is the policy of The University of Chicago Pritzker School of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its individually provided or jointly provided educational activities. Individuals who are in a position to control the content of any educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Mechanisms to ensure that presentations are free from commercial bias are in place. Faculty will also disclose any off-label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.

The mission of Spring to Life™ is to reflect and transmit all that is evolving in the whole of the field of oncology. The annual conference continues to bring together faculty speakers that reflect local, regional and national expertise in the field. This collaboration of community-based oncologists with academic leaders highlights the impact of the research that advances our understanding and ultimately impacts the lives of our patients whom we serve.

Click on the links below to view the programs from years past.

2014 The Acute Leukemias - AML and ALL

2015 Aggresive B-Cell Non-Hodgkin Lymphomas

2016 Plasma Cell Diseases

2017 Myeloproliferative Neoplasms (MPNs)

2018 Incident Lymphoid Malignancies

2019 Harnessing the Power of our Immune System in Cancer Therapy

2020 Lung Cancer

2021 Leukemias

Thank you to the collaborators, educational grant providers, sponsors and exhibitors, past and present, who have made this event possible:

AbbVie, Inc.
AbbVie Oncology
ADC Therapeutics
Alexion Pharmaceuticals, Inc.
Amgen (Oncology and Hematology)
Amyloidosis Support Groups
Astellas Pharma US, Inc.
AstraZeneca US
Be The Match
BeiGene
Boehringer Ingelheim
Bristol-Myers Squibb
Bristol-Myers Squibb Oncology
Cancer Hope Network
Caris Life Sciences
Celgene Corporation
CLL Support Group of Albany
CRAAB
Eisai Oncology, Inc.
Epizyme, Inc.
Exelixis, Inc.
Foundation Medicine
Genentech USA, Inc.
Genomic Health, Inc.

Genoptix, A NeoGenomics Company
Gilead Sciences, Inc.
GlaxoSmithKline
Global Blood Therapeutics, Inc.
Guardant Health, Inc.
Incyte Corporation
Janssen Biotech, Inc.
Janssen Pharmaceuticals, Inc
Jazz Pharmaceuticals plc
Kite Pharma
Leukemia & Lymphoma Society
Lilly USA, LLC
Lung Cancer Research Foundation
Maddie’s Mark
Make-A-Wish Northeast New York
Med News Online
Melodies Center at the Children’s Hospital, Albany
- Medical Center
Merck
Millennium Pharmaceuticals, Inc.
Morphosys US
NeoGenomics Laboratories, Inc
New York Oncology Hematology
Nick’s Fight to be Healed Foundation

Novartis
Novartis Hematology
Novartis Oncology Onyx Pharmaceuticals, Inc.
Oncopeptides
Otsuka America Pharmaceutical, Inc.
Pfizer
Pfizer Oncology
Pharmacyclics LLC, an AbbVie Company
Prometheus
Rigel Pharmaceuticals
Sandoz BioPharmaceuticals
Sanofi-Genzyme & Regeneron
Seattle Genetics, Inc.
Shire
Spectrum Pharmaceuticals
Stemline Therapeutics
Susan G. Komen
Taiho
Takeda Hematology
Takeda Oncology
Teva Pharmaceutical Industries Ltd.
TG Therapeutics
Verastem, Inc.

The 9th Annual Spring to Life: Conference on Gastrointestinal Cancers 2022 is going to be held online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events. The conference will be recorded and will be offered on-demand for 30 days following the conference.

DOWNLOAD AGENDA

A virtual tradeshow platform is available to exhibitors. The platform has been enhanced to include features, benefits, and functionality in an attempt to increase the value of the sponsorship opportunities.

Conference attendees can visit booths and interact with exhibitors during conference and the virtual tradeshow will remain live for 30 days following the conference.

DOWNLOAD SUPPORT OPPORTUNITIES

ONLINE EXHIBIT APPLICATION

Conference Organizers Contact Information:

1-800-973-0665
exhibits@mymededco.com

To view previous years' programs, collaborators, educational grant providers, sponsors and exhibitors, please click here.